Ideal cardiovascular health, glycaemic status and incident type 2 diabetes mellitus: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
African-Americans
Diabetes
Ideal cardiovascular health
Impaired fasting glucose
Life’s simple 7
Journal
Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
14
10
2018
accepted:
01
11
2018
pubmed:
16
1
2019
medline:
25
6
2019
entrez:
16
1
2019
Statut:
ppublish
Résumé
Ideal cardiovascular health (CVH) is associated with lower diabetes risk. However, it is unclear whether this association is similar across glycaemic levels (normal [<5.6 mmol/l] vs impaired fasting glucose [IFG] [5.6-6.9 mmol/l]). A secondary data analysis was performed in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Incident diabetes was assessed among 7758 participants without diabetes at baseline (2003-2007) followed over 9.5 years. Baseline cholesterol, blood pressure, diet, smoking, physical activity and BMI were used to categorise participants based on the number (0-1, 2-3 and ≥4) of ideal CVH components. Risk ratios (RRs) were calculated using modified Poisson regression, adjusting for cardiovascular risk factors. Among participants (mean age 63.0 [SD 8.4] years, 56% female, 73% white, 27% African-American), there were 891 incident diabetes cases. Participants with ≥4 vs 0-1 ideal CVH components with normal fasting glucose (n = 6004) had 80% lower risk (RR 0.20; 95% CI 0.10, 0.37), while participants with baseline IFG (n = 1754) had 13% lower risk (RR 0.87; 95% CI 0.58, 1.30) (p for interaction by baseline glucose status <0.0001). Additionally, the magnitude of the association of ideal CVH components with lower diabetes risk was stronger among white than African-American participants (p for interaction = 0.0338). A higher number of ideal CVH components was associated with a dose-dependent lower risk of diabetes for participants with normal fasting glucose but not IFG. Tailored efforts that take into account observed differences by race and glycaemic level are needed for the primordial prevention of diabetes.
Identifiants
pubmed: 30643923
doi: 10.1007/s00125-018-4792-y
pii: 10.1007/s00125-018-4792-y
pmc: PMC6392040
mid: NIHMS1518704
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
426-437Subventions
Organisme : ACL HHS
ID : U01DP006302
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK117041
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK079626
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR000032
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL080477
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL165452
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS041588
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP006302
Pays : United States
Références
J Am Heart Assoc. 2017 Jun 21;6(6):
pubmed: 28637777
Stroke. 2013 Jul;44(7):1909-14
pubmed: 23743971
Hypertension. 2014 Jun;63(6):1212-8
pubmed: 24711519
Ann Intern Med. 2011 Sep 6;155(5):292-9
pubmed: 21893622
JAMA. 2011 Apr 20;305(15):1545-52
pubmed: 21482744
J Clin Endocrinol Metab. 2016 Apr;101(4):1770-8
pubmed: 26908112
Diabetes Care. 2014 Aug;37(8):2240-5
pubmed: 24804696
Stroke. 2013 Sep;44(9):2519-24
pubmed: 23868271
J Clin Epidemiol. 1990;43(12):1327-35
pubmed: 2254769
Health Place. 2017 Mar;44:61-69
pubmed: 28167269
JAMA. 2014 Sep 24;312(12):1218-26
pubmed: 25247518
Diabetologia. 2016 Sep;59(9):1893-903
pubmed: 27272340
Circulation. 2012 Jan 3;125(1):45-56
pubmed: 22095826
Arch Intern Med. 2009 Apr 27;169(8):798-807
pubmed: 19398692
Hypertension. 2016 Jan;67(1):56-62
pubmed: 26573703
N Engl J Med. 1991 Mar 14;324(11):733-9
pubmed: 1997839
J Am Coll Cardiol. 2011 Apr 19;57(16):1690-6
pubmed: 21492767
Diabetes Care. 2011 Apr;34(4):873-9
pubmed: 21346180
Diabetes Care. 2016 Aug;39 Suppl 2:S115-20
pubmed: 27440823
Circulation. 2010 Feb 2;121(4):586-613
pubmed: 20089546
Circulation. 2012 Feb 28;125(8):987-95
pubmed: 22291126
Lancet. 2017 Apr 8;389(10077):1399-1409
pubmed: 28237263
Neuroepidemiology. 2005;25(3):135-43
pubmed: 15990444
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Ann Neurol. 2008 Nov;64(5):507-13
pubmed: 19067365
Arch Intern Med. 2011 Aug 8;171(15):1352-60
pubmed: 21824948
Clin Biochem. 2014 Nov;47(16-17):243-6
pubmed: 25130959
Front Nutr. 2015 Jan 19;1:29
pubmed: 25988129
Am J Prev Med. 2017 Nov;53(5):e165-e174
pubmed: 28818415